南美洲和中美洲肾脏疾病市场预测至 2027 年 - COVID-19 影响和按产品划分的区域分析(诊断和治疗);最终用户(医院、诊断实验室等);和国家

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 136    |    Report Code: TIPRE00016076    |    Category: Life Sciences

Explore in Your Language
South and Central America Kidney Disease Market

市场介绍

肾脏疾病是指肾脏受损,无法正常过滤血液。这种损害会导致废物在体内堆积。糖尿病和高血压是肾脏疾病的最常见原因。肾脏疾病有多种类型,包括肾结石、肾小球肾炎、尿路感染等。

市场概况和动态

<南方与南方中美洲肾脏疾病市场预计将从 2019 年的 57.589 亿美元增至 2027 年的 90.609 亿美元。预计 2020-2027 年该市场将以 5.9% 的复合年增长率增长。预计该市场的增长将归因于关键驱动因素,例如南部和南部地区肾脏疾病的患病率较高。中美洲高血压发病率不断上升。然而,由于没有足够的劳动力来应对肾脏疾病的负担,预计该市场在预测期内增长缓慢。

关键细分市场

从产品上看,肾病市场是细分的诊断和治疗。诊断部分进一步细分为血液检查、尿液检查、影像检查等。治疗部分进一步细分为透析、药物类别等。该药物类别细分为 ACE 抑制剂、血管紧张素 2 受体阻滞剂、利尿剂等。根据最终用户,肾脏疾病市场分为医院、诊断实验室等。

 

主要来源和上市公司

报告中包含的一些主要的肾脏疾病市场主要来源包括巴西肾脏病学会、拉丁美洲透析和移植登记处.

 

购买报告的理由

  • 了解南方和南方中美洲肾脏疾病市场格局并确定最有可能保证强劲回报的细分市场
  • 了解肾脏疾病市场不断变化的竞争格局,保持领先地位
  • 高效规划南部和南部地区的并购和合作交易通过识别最有前景的可能销售的细分市场,中美洲肾脏疾病市场
  • 通过对肾脏疾病市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • 获取南部和南部地区各细分市场 2019 年至 2027 年的市场收入预测中美洲地区

 

南美地区中美洲肾脏疾病市场细分

 

按产品

·          诊断

o      血液测试

o      尿液测试

o     成像测试

o      其他

·        治疗

o      透析

o      其他

o      药物类别

§   ACE抑制剂

§   血管紧张素-II 受体阻滞剂

§   利尿剂

§   其他

 

最终用户

·     ;     医院

·         诊断实验室

·        其他

 

按国家/地区

·          南和南中美洲

o      巴西

o      阿根廷

公司简介

  • 雅培
  • F.霍夫曼-拉罗氏有限公司
  • 艾伯维公司
  • 辉瑞公司
  • 梯瓦制药工业公司有限公司
  • 葛兰素史克公司
  • 希森美康公司
  • 西门子股份公司
  • 安进公司
 

South and Central America Kidney Disease Strategic Insights

Strategic insights for South and Central America Kidney Disease involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-kidney-disease-market-strategic-framework.webp
Get more information on this report

South and Central America Kidney Disease Report Scope

Report Attribute Details
Market size in 2019 US$ 5,758.9 Million
Market Size by 2027 US$ 9,060.9 Million
Global CAGR (2020 - 2027) 5.9%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 产品
  • 诊断和治疗
By 最终用户
  • 医院
  • 诊断实验室
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Sysmex Corporation
  • Siemens AG
  • Amgen Inc.
  • Get more information on this report

    South and Central America Kidney Disease Regional Insights

    The regional scope of South and Central America Kidney Disease refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-kidney-disease-market-geography.webp
    Get more information on this report

    The List of Companies - South and Central America Kidney Disease Market

    The List of Companies - South and Central America Kidney Disease Market

    1. Abbott
    2. F. Hoffmann-La Roche Ltd
    3. AbbVie Inc.
    4. Pfizer Inc.
    5. Teva Pharmaceutical Industries Ltd
    6. GlaxoSmithKline plc.
    7. Sysmex Corporation
    8. Siemens AG
    9. Amgen Inc.
    Frequently Asked Questions
    How big is the South and Central America Kidney Disease Market?

    The South and Central America Kidney Disease Market is valued at US$ 5,758.9 Million in 2019, it is projected to reach US$ 9,060.9 Million by 2027.

    What is the CAGR for South and Central America Kidney Disease Market by (2020 - 2027)?

    As per our report South and Central America Kidney Disease Market, the market size is valued at US$ 5,758.9 Million in 2019, projecting it to reach US$ 9,060.9 Million by 2027. This translates to a CAGR of approximately 5.9% during the forecast period.

    What segments are covered in this report?

    The South and Central America Kidney Disease Market report typically cover these key segments-

  • 产品 (诊断和治疗)
  • 最终用户 (医院, 诊断实验室)
  • What is the historic period, base year, and forecast period taken for South and Central America Kidney Disease Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Kidney Disease Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in South and Central America Kidney Disease Market?

    The South and Central America Kidney Disease Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Sysmex Corporation
  • Siemens AG
  • Amgen Inc.
  • Who should buy this report?

    The South and Central America Kidney Disease Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South and Central America Kidney Disease Market value chain can benefit from the information contained in a comprehensive market report.